LACSOFT
Brand:
LACSOFT
Manufacturer:
IPCA
Manufacturer Details
IPCA
Compositions:
Lactic acid 125% w/v cream,
|
Strength
|
Rate
|
Packing Style
|
|
125% w/v
|
154.00
|
50g cream
|
|
125%w/v
|
350.00
|
140g cream
|
List of Related Indications:
- Prolonged menstruation- prevention
List Of Drugs:
- Lactic Acid- (FDC- List )-(Apr 2008)
Indication Type Description:
Drug Interaction:
Reports not available
Indication:
U.S. FDA APPROVED DRUGS FROM 01-01-08 TO 31-12-08
Drug name Indication Date of Approval
111. Live freeze -dried Lactic acid bacteria 10-04-08
and bifidobacteria capsules
For the treatment of irritable bowel syndrome
Preventive measures during temporary imbalances ( prolonged menstuation after menopause Bacterial vaginosis
New drugs approved For Marketing by Drug Controller General of India(DCGI )
during the period January 1988 to November 2014
(Ref- IDMA Annual Publication 2015)
Name of Drug Indication Date of Approval
1.Combination of Lactic acid Bacteria 08-04-2013
VSL#3 Sachet
For mild to moderartely active ulcerative colitis as an adjunctive therapy
subject to condition that it should not be used in patients who are on
steroids or immunocompromised
2.Live Freeze dried Lactic acid 10-04-2008
Bacteria and endobacteria capsules
For the treatment of irritable bowel syndrome
FIXED DOSE COMBINATIONS APPROVED BY DCG(I)
FROM JANUARY 1961 TILL NOVEMBER 2014
Name of Drug Indication Date of Approval
Lactic acid 1.0% w/v+ 06-11-1995
Lactoserum 0.9% w/v for topical use
Contra-Indications:
Blood mixed discharges Women expecting surgery
Dosages/ Overdosage Etc:
Preventive measures during temporary imbalances ( prolonged menstuation after menopause Bacterial vaginosis
Dosage-
1 tube daily intravaginally preferably at bed time for 7 days
Prevention of bacterial vaginosis-
1 tube at bed time for 2 -3 days
